APONTIS PHARMA AGAPONTIS PHARMA AGAPONTIS PHARMA AG

APONTIS PHARMA AG

No trades
See on Supercharts
Market capitalization
‪70.89 M‬EUR
−1.32EUR
‪−11.30 M‬EUR
‪37.00 M‬EUR
‪4.66 M‬
Beta (1Y)
−0.13

About APONTIS PHARMA AG

CEO
Bruno Wohlschlegel
Headquarters
Monheim am Rhein
Founded
2018
ISIN
DE000A3CMGM5
FIGI
BBG0107RVJ78
APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. Its single pill products focus on cardiovascular diseases such as hypertension, hyperlipidemia, and secondary prevention. The company was founded on March 19, 2018 and is headquartered in Monheim am Rhein, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of APPH is 8.24 EUR — it has decreased by 1.20% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange APONTIS PHARMA AG stocks are traded under the ticker APPH.
APPH stock is 3.92% volatile and has beta coefficient of −0.13. Check out the list of the most volatile stocks — is APONTIS PHARMA AG there?
One year price forecast for APONTIS PHARMA AG has a max estimate of 20.00 EUR and a min estimate of 16.00 EUR.
Yes, you can track APONTIS PHARMA AG financials in yearly and quarterly reports right on TradingView.
APPH stock has risen by 4.30% compared to the previous week, the month change is a 38.26% rise, over the last year APONTIS PHARMA AG has showed a 18.42% decrease.
APPH net income for the last quarter is ‪−7.78 M‬ EUR, while the quarter before that showed ‪−3.52 M‬ EUR of net income which accounts for −120.89% change. Track more APONTIS PHARMA AG financial stats to get the full picture.
Today APONTIS PHARMA AG has the market capitalization of ‪69.47 M‬, it has increased by 20.85% over the last week.
No, APPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, APPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APONTIS PHARMA AG stock right from TradingView charts — choose your broker and connect to your account.
APPH reached its all-time high on Sep 28, 2021 with the price of 27.80 EUR, and its all-time low was 3.04 EUR and was reached on Nov 9, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APONTIS PHARMA AG technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APONTIS PHARMA AG stock shows the buy signal. See more of APONTIS PHARMA AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on APONTIS PHARMA AG future price: according to them, APPH price has a max estimate of 20.00 EUR and a min estimate of 16.00 EUR. Read a more detailed APONTIS PHARMA AG forecast: see what analysts think of APONTIS PHARMA AG and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APONTIS PHARMA AG EBITDA is ‪−15.93 M‬ EUR, and current EBITDA margin is −35.68%. See more stats in APONTIS PHARMA AG financial statements.